| For: | Pan WX, Zhang XM, Hao SL, Han W. Progress in immunotherapy for neuroendocrine neoplasm of the digestive system. World J Gastroenterol 2023; 29(26): 4174-4185 [PMID: 37475845 DOI: 10.3748/wjg.v29.i26.4174] | 
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v29/i26/4174.htm | 
| Number | Citing Articles | 
| 1 | 
                                            Christian Fottner, Leonidas Apostolidis, Sebastian Krug, Anja Rinke, Barbara Grün, Patrick Michl, Thomas M. Gress, Daniel-Christoph Wagner, Wilfried Roth, Esther Mettler, Jana Topsch, Christian Ruckes, Peter R. Galle, Matthias M. Weber. Activity and Safety of Avelumab in High-Grade Neuroendocrine Tumors and Poorly Differentiated Neuroendocrine Carcinomas Progressive after Chemotherapy (AveNEC Trial). Clinical Cancer Research 2025; 31(5): 860 doi: 10.1158/1078-0432.CCR-24-2461
                                         | 
| 2 | 
                                            Ingrid Raponi, Rossana Moi, Alessandra Perfetti, Angela Palma, Silvana Giacinti, Michele Battista, Piero Luigi Alò, Cecilia Nisticò, Andrea Marzetti. Neuroendocrine carcinomas of the larynx: a review of current literature and case analysis. Journal of Surgical Case Reports 2025; 2025(6) doi: 10.1093/jscr/rjaf410
                                         | 
| 3 | 
                                            John Patresan, Harsh Patel , Angelica Singh. A Neuroendocrine Tumor of Unknown Primary Origin: A Case Report and Review of the Literature. Cureus 2024;  doi: 10.7759/cureus.65200
                                         | 
| 4 | 
                                            Christine Son, Joshua Kalapala, Jeff Leya, Michelle Marion Popadiuk, Mohammed K. Atieh, Daniel Havlichek, Lawrence Feldman, Paul Roach, Promila Banerjee. Gastroesophageal Neuroendocrine Tumors: Outcomes and Management. Journal of Clinical Medicine 2025; 14(7): 2148 doi: 10.3390/jcm14072148
                                         | 
| 5 | 
                                            Nastasiia Artamonova, Isabel Heidegger. Urologic Cancers - Advances and Challenges in Diagnosis and Molecular Targeted Therapy [Working Title]. 2025;  doi: 10.5772/intechopen.1009816
                                         | 
| 6 | 
                                            Xuan-Peng Zhou, Luan-Biao Sun, Wen-Hao Liu, Xin-Yuan Song, Yang Gao, Jian-Peng Xing, Shuo-Hui Gao. Development and validation of predictive models for distant metastasis and prognosis of gastroenteropancreatic neuroendocrine neoplasms. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-92974-x
                                         | 
| 7 | 
                                            Jaewoo Park, Min Sung Joo, Myung Jun Kim, Seungseok Oh, Phuong Thao Tran, Minju Kwon, Yong June Choi, JaeYung Lee, Eun-Jung Kim, Dong Hyuk Ki, Hunmi Choi, Wooseok Han, Keon Wook Kang. High cereblon expression in neuroendocrine cancer confers vulnerability to GSPT1 molecular glue degrader. Experimental Hematology & Oncology 2025; 14(1) doi: 10.1186/s40164-025-00674-z
                                         | 
| 8 | 
                                            舒瑶 张. A Case Report of Nonfunctional Pelvic Neuroendocrine Tumor. Advances in Clinical Medicine 2023; 13(11): 18448 doi: 10.12677/ACM.2023.13112591
                                         | 
| 9 | 
                                            Adam W. Beck, Herbert Chen, Bin Ren. Arteriolar angiogenesis: implications in anti-angiogenic immunotherapy for pancreatic cancers. Cytokine & Growth Factor Reviews 2025; 86: 96 doi: 10.1016/j.cytogfr.2025.10.002
                                         | 

 
         
                         
                 
                 
                 
                 
                 
                         
                         
                        